ArticleBMC nephrology2026
A retrospective cohort study on the association between RAR and mortality in peritoneal Dialysis patients.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInflammation and malnutrition collectively constitute the dual challenge that predominantly shapes the prognosis of peritoneal dialysis (PD) patients. As a composite biomarker, the red cell distribution width-to-albumin ratio (RAR) integrates these two pathological dimensions into a single numerical value. Although RAR has demonstrated superior prognostic value across multiple diseases, the association with mortality in the PD population remains unexplored.
methodsThis single-institution retrospective cohort investigation enrolled 394 individuals initiating peritoneal dialysis from January 2015 to December 2022 at Shaoxing People’s Hospital and followed them until May 2025. The optimal RAR cutoff for predicting mortality was established via ROC curve analysis, with discriminative performance evaluated based on the AUC value. Kaplan-Meier survival curves were plotted to compare survival rates between groups, with differences assessed using the log-rank test. Hazard ratios (HR) were calculated after adjusting for potential confounders via multivariate Cox proportional hazards regression models, supplemented by subgroup analyses and interaction analyses.
resultsOver the study period, 97 patients (24.6%) died. ROC analysis established 4.619 as the optimal RAR cutoff for mortality prediction, demonstrating significant discriminatory value with an AUC of 0.819 (P < 0.001). Compared with the C-reactive protein-to-albumin ratio and the prognostic nutritional index, RAR showed a better prognostic ability. When applying the cutoff of 4.619, patients with high RAR exhibited significantly worse survival (log-rank P < 0.001). The adjusted hazard ratio for all-cause mortality associated with high RAR was 2.498 (95% CI 1.887–3.306; P < 0.001), confirming a stable and significant association after controlling for multiple covariates. This association showed no significant heterogeneity across subgroups defined by different clinical characteristics, confirming the robustness of the finding.
conclusionBased on its significant association with all-cause mortality in peritoneal dialysis patients, RAR demonstrates potential as a practical tool for clinical risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.